The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Clinically relevant drug interactions with antiepileptic drugs
Open accessAbstract
Some patients with difficult‐to‐treat epilepsy benefit from combination therapy with two or more antiepileptic drugs (AEDs). Additionally, virtually all epilepsy patients will receive, at some time in their lives, other medications for the management of associated conditions. In these situations, clinically important drug interactions may occur. Carbamazepine, phenytoin, phenobarbital and primidone induce many cytochrome P450 (CYP) and glucuronyl transferase (GT) enzymes, and can reduce drastically the serum concentration of associated drugs which are substrates of the same enzymes. Examples of agents whose serum levels are decreased markedly by enzyme‐inducing AEDs, include lamotrigine, tiagabine, several steroidal drugs, cyclosporin A, oral anticoagulants and many cardiovascular, antineoplastic and psychotropic drugs. Valproic acid is not enzyme inducer, but it may cause clinically relevant drug interactions by inhibiting the metabolism of selected substrates, most notably phenobarbital and lamotrigine. Compared with older generation agents, most of the recently developed AEDs are less likely to induce or inhibit the activity of CYP or GT enzymes. However, they may be a target for metabolically mediated drug interactions, and oxcarbazepine, lamotrigine, felbamate and, at high dosages, topiramate may stimulate the metabolism of oral contraceptive steroids. Levetiracetam, gabapentin and pregabalin have not been reported to cause or be a target for clinically relevant pharmacokinetic drug interactions. Pharmacodynamic interactions involving AEDs have not been well characterized, but their understanding is important for a more rational approach to combination therapy. In particular, neurotoxic effects appear to be more likely with coprescription of AEDs sharing the same primary mechanism of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux
Synold, T. W., Dussault, I., & Forman, B. M. (2001) · Nature Medicine · doi:10.1038/87912 · Cited by 840
Changes in plasma protein binding have little clinical relevance
Benet, L. Z., & Hoener, B. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.121829 · Cited by 825
The importance of drug interactions in epilepsy therapy
Patsalos, P. N., Fröscher, W., Pisani, F., & Van Rijn, C. M. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.13001.x · Cited by 455
Patsalos, P. N., & Perucca, E. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00409-5 · Cited by 423
Self-citationPatsalos, P. N., & Perucca, E. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00483-6 · Cited by 391
Self-citationDrugs as P-glycoprotein substrates, inhibitors, and inducers
Kim, R. B. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001389 · Cited by 382
Interactions between antiepileptic and chemotherapeutic drugs
Vecht, C. J., Wagner, G. L., & Wilms, E. B. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00435-6 · Cited by 256
Sodium valproate acutely inhibits lamotrigine metabolism.
Yuen, A., Land, G., Weatherley, B., & Peck, A. (1992) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1992.tb04079.x · Cited by 252
Oral contraceptives reduce lamotrigine plasma levels
Sabers, A., Öhman, I., Christensen, J., & Tomson, T. (2003) · Neurology · doi:10.1212/01.wnl.0000076485.09353.7a · Cited by 250
Pisani, F., Oteri, G., Russo, M. F., Di Perri, R., Perucca, E., & Richens, A. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00832.x · Cited by 247
Self-citationA Mechanistic Approach to Antiepileptic Drug Interactions
Anderson, G. D. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17332 · Cited by 246
Clinically Important Drug Interactions with Anticoagulants: An Update
Harder, S., & Thürmann, P. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630060-00002 · Cited by 227
Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy
(2000) · Epilepsia · doi:10.1111/j.1499-1654.2000.001597.x · Cited by 225
Lamotrigine plasma levels reduced by oral contraceptives
Sabers, A., Buchholt, J. M., Uldall, P., & Hansen, E. L. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(01)00305-9 · Cited by 219
Macrolide Antibacterials: Drug Interactions of Clinical Significance
von Rosenstiel, N.-A., & Adam, D. (1995) · Drug Safety · doi:10.2165/00002018-199513020-00005 · Cited by 212
Rosenfeld, W. E., Doose, D. R., Walker, S. A., & Nayak, R. K. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01123.x · Cited by 210
In Vitro Approaches to Predicting Drug Interactions In Vivo
von Moltke, L. L., Greenblatt, D. J., Schmider, J., Wright, C. E., Harmatz, J. S., & Shader, R. I. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00239-6 · Cited by 197
Acute Effects of Lamotrigine (BW430C) in Persons With Epilepsy
Binnie, C. D., Boas, W. V. E., Kasteleijn‐Nolste‐Trenite, D. G. A., de Korte, R. A., Meijer, J. W. A., Meinardi, H., Miller, A. A., Overweg, J., Peck, A. W., van Wieringen, A., et al. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb03536.x · Cited by 189
Perucca, E., Hedges, A., Makki, K., Ruprah, M., Wilson, J., & Richens, A. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02482.x · Cited by 189
Self-citationInteractions Between Antiepileptic Drugs and Hormonal Contraception
Crawford, P. (2002) · CNS Drugs · doi:10.2165/00023210-200216040-00005 · Cited by 189
Pharmacokinetic Interactions of Topiramate
Bialer, M., Doose, D. R., Murthy, B., Curtin, C., Wang, S.-S., Twyman, R. E., & Schwabe, S. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443120-00001 · Cited by 182
The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids.
Crawford, P., Chadwick, D., Martin, C., Tjia, J., Back, D., & Orme, M. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb05457.x · Cited by 179
GIESSMANN, T., MAY, K., MODESS, C., WEGNER, D., HECKER, U., ZSCHIESCHE, M., DAZERT, P., GRUBE, M., SCHROEDER, E., & WARZOK, R. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.04.011 · Cited by 167
Carbamazepine Toxicity with Lamotrigine: Pharmacokinetic or Pharmacodynamic Interaction?
Besag, F. M. C., Berry, D. J., Pool, F., Newbery, J. E., & Subel, B. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01356.x · Cited by 161
Doose, D. R., Wang, S., Padmanabhan, M., Schwabe, S., Jacobs, D., & Bialer, M. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.55602.x · Cited by 161
Valproate-Ethosuximide Combination Therapy for Refractory Absence Seizures
Rowan, A. J., Meijer, J. W. A., de Beer-Pawlikowski, N. K. B., van der Geest, P., & Meinardi, H. (1983) · Archives of Neurology · doi:10.1001/archneur.1983.04050120047006 · Cited by 149
Implications of Cytochrome P450 Interactions When Prescribing Medication for Hypertension
Flockhart, D. A., & Tanus-Santos, J. E. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.4.405 · Cited by 145
Clinical Significance of Pharmacokinetic Interactions Between Antiepileptic and Psychotropic Drugs
Spina, E., & Perucca, E. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.043s2037.x · Cited by 143
Self-citationNew Antiepileptic Drugs: Review on Drug Interactions
Hachad, H., Ragueneau, I., & Levy, R. H. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200202000-00016 · Cited by 134
Clinical pharmacology and therapeutic use of the new antiepileptic drugs
Perucca, E. (2001) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2001.00055.x · Cited by 118
Self-citationInteraction between phenytoin and valproic acid: Plasma protein binding and metabolic effects
Perucca, E., Hebdige, S., Frigo, G. M., et al. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.235 · Cited by 118
Self-citationA Review of Enzyme Induction of Warfarin Metabolism with Recommendations for Patient Management
Cropp, J. S., & Bussey, H. I. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03782.x · Cited by 108
Serum Concentrations of Lamotrigine in Epileptic Patients: The Influence of Dose and Comedication
May, T. W., Rambeck, B., & Jürgens, U. H. (1996) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199610000-00001 · Cited by 105
Christiansen, J., & Dam, M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1973.tb01327.x · Cited by 103
Krauss, G. L., Brandt, J., Campbell, M. J., Plate, C., & Summerfield, M. (1996) · Neurology · doi:10.1212/wnl.46.6.1534 · Cited by 103
Oxcarbazepine: Pharmacokinetic Interactions and Their Clinical Relevance
Baruzzi, A., Albani, F., & Riva, R. (1994) · Epilepsia · doi:10.1111/j.1528-1157.1994.tb05939.x · Cited by 101
Mechanism of valproate-phenobarbital interaction in epileptic patients
Kapetanović, I. M., Kupferberg, H. J., Porter, R. J., Theodore, W. H., Schulman, E. A., & Penry, J. K. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.66 · Cited by 89
Turck, B. J. D., Diltoer, M., Cornelis, P. J., et al. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.4.563 · Cited by 88
Bartoli, A., Guerrini, R., Belmonte, A., et al. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199706000-00002 · Cited by 84
Carbamazepine–Indinavir Interaction Causes Antiretroviral Therapy Failure
Hugen, P. W. H., Burger, D. M., Brinkman, K., ter Hofstede, H. J., Schuurman, R., Koopmans, P. P., & Hekster, Y. A. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19211 · Cited by 84
Clinical Observations of Possible Barbiturate Interference With Anticoagulation
MacDonald, M. G. (1968) · JAMA · doi:10.1001/jama.1968.03140150001001 · Cited by 79
Tartara, A., Galimberti, C. A., Manni, R., MORINI, R., Limido, G., Gatti, G., Bartoli, A., STRADA, G., & Perucca, E. (1993) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1993.tb00378.x · Cited by 79
Self-citationClinically Important Drug Interactions
Prescott, L. F. (1973) · Drugs · doi:10.2165/00003495-197305030-00001 · Cited by 79
Ducharme, M. P., Slaughter, R. L., Warbasse, L. H., Chandrasekar, P. H., de Velde, V. V., Mannens, G., & Edwards, D. J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90017-9 · Cited by 78
Drug Treatment of Epilepsy in Elderly People: Focus on Valproic Acid
Stephen, L. J. (2003) · Drugs & Aging · doi:10.2165/00002512-200320020-00005 · Cited by 75
Gender difference in management of epilepsy—what women are hearing
Crawford, P. M., & Lee, P. (1999) · Seizure · doi:10.1053/seiz.1999.0274 · Cited by 74
Discontinuation of Phenytoin and Carbamazepine in Patients Receiving Felbamate
Wagner, M., Graves, N. M., Marienau, K., Holmes, G. B., Remmel, R. P., & Leppik, I. E. (1991) · Epilepsia · doi:10.1111/j.1528-1157.1991.tb04669.x · Cited by 70
Romanelli, F., Jennings, H. R., Nath, A., Ryan, M. A., & Berger, J. R. (2000) · Neurology · doi:10.1212/wnl.54.7.1404 · Cited by 69
Bounds, W., & Guillebaud, J. (2002) · Journal of Family Planning and Reproductive Health Care · doi:10.1783/147118902101195992 · Cited by 69
Ojemann, L. M., Shastri, R., Wilensky, A. J., Friel, P. N., Levy, R. H., McLean, J. R. N., & Buchanan, R. A. (1986) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198609000-00010 · Cited by 67
Armijo, J. A., Bravo, J., Cuadrado, A., & Herranz, J. L. (1999) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199904000-00008 · Cited by 66
Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs
Perucca, E. (1987) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(87)90042-8 · Cited by 63
Self-citationInteractions Between Clobazam and Standard Antiepileptic Drugs in Patients with Epilepsy
Sennoune, S. R., Mesdjian, E., Bonneton, J., Genton, P., Dravet, C., & Roger, J. (1992) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199208000-00002 · Cited by 62
Serum Concentrations of Valproic Acid
May, T., & Rambeck, B. (1985) · Therapeutic Drug Monitoring · doi:10.1097/00007691-198512000-00004 · Cited by 60
Sodium Valproate and Valpromide: Differential Interactions with Carbamazepine in Epileptic Patients
Pisani, F., Fazio, A., Oteri, G., et al. (1986) · Epilepsia · doi:10.1111/j.1528-1157.1986.tb03582.x · Cited by 52
Influence of Phenytoin and phenobarbital on the disposition of a single oral dose of clonazepam
Khoo, K., Mendels, J., Rothbart, M., et al. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.175 · Cited by 34
Status Epilepticus Associated with the Combination of Valproic Acid and Clomipramine
DeToledo, J. C., Haddad, H., & Ramsay, R. E. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199702000-00012 · Cited by 33
Reduced Plasma Nisoldipine Concentrations in Phenytoin‐Treated Patients with Epilepsy
Michelucci, R., Cipolla, G., Passarelli, D., et al. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb01032.x · Cited by 26
Serum Valproate Levels with Oral Contraceptive Use
Herzog, A. G., Farina, E. L., & Blum, A. S. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00605.x · Cited by 24
Battino, D., Croci, D., Granata, T., et al. (1992) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199210000-00006 · Cited by 24
Factors contributing to carbamazepine–macrolide interactions
Pauwels, O. S. G. (2002) · Pharmacological Research · doi:10.1006/phrs.2002.0957 · Cited by 24
METABOLISM-BASED DRUG INTERACTIONS INVOLVING ORAL AZOLE ANTIFUNGALS IN HUMANS*
Benedetti, M. S., & Bani, M. (1999) · Drug Metabolism Reviews · doi:10.1081/dmr-100101941 · Cited by 24
Hassan, Y., Awaisu, A., Aziz, N. A., et al. (2005) · Pharmacy World & Science · doi:10.1007/s11096-004-5150-3 · Cited by 14
Cited by
Glioblastoma and Other Malignant Gliomas: A Clinical Review
Omuro, A. (2013) · JAMA · doi:10.1001/jama.2013.280319 · Cited by 2,301
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Adverse effects of antiepileptic drugs
Perucca, P., & Gilliam, F. G. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70153-9 · Cited by 694
A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin
Bockbrader, H. N., Wesche, D., Miller, R., Chapel, S., Janiczek, N., & Burger, P. (2010) · Clinical Pharmacokinetics · doi:10.2165/11536200-000000000-00000 · Cited by 690
Inhibition and induction of human cytochrome P450 enzymes: current status
Pelkonen, O., Turpeinen, M., Hakkola, J., Honkakoski, P., Hukkanen, J., & Raunio, H. (2008) · Archives of Toxicology · doi:10.1007/s00204-008-0332-8 · Cited by 569
Metadata
- Authors
- Perucca, E.
- Venue
- British Journal of Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2005-10-27
- Volume
- 61
- Issue
- 3
- Pages
- 246-255
- ISSN
- 0306-5251 (ISSN-L)
- 1365-2125
- OpenAlex
- W2069987842
- Cited by
- 602
- References
- 63
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.